Molina Healthcare stock (US60855R1005): Wall Street sees hold stance

Molina Healthcare's New York listing drew fresh attention on Sunday as MarketBeat's latest consensus showed a hold stance and a $178.53 average price target, while the shares closed at $173.61 on 05/29/2026.

Molina Healthcare's New York-listed shares were in focus on Sunday after MarketBeat's latest consensus page showed 16 analysts with an average price target of $178.53 and a hold rating, versus a last closing price of $173.61 on 05/29/2026. The stock is listed on the NYSE in the United States under ticker MOH, and the latest consensus data imply a modest gap between the market price and Wall Street's average forecast.

The same data set also shows a high target of $250.00 and a low target of $124.00, underscoring how wide the current analyst range remains around the managed-care name. MarketBeat's forecast page is dated 05/31/2026 and places the consensus upside at 2.83% from the cited closing price, a point that keeps the U.S. home-market angle central for investors following the stock on the NYSE.

As of: 05/31/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Molina Healthcare
• Sector/industry: Managed care and health insurance
• Headquarters/country: Long Beach, United States
• Core markets: United States
• Key revenue drivers: Premium revenue from government-sponsored health plans
• Home exchange/listing venue: NYSE (MOH)
• Trading currency: USD

Molina Healthcare: core business model

Molina Healthcare runs a government-focused managed-care business that sells health coverage through public programs in the United States, with premium income as the main economic engine.

Chart technicals and 52-week range

The latest MarketBeat data show Molina Healthcare closing at $173.61 on 05/29/2026, with extended trading at $173.65 shortly after the close. The same page lists a 52-week range of $160.31 to $365.23, which places the shares nearer the lower end of that band than the upper end.

For chart watchers, that range frames the stock's recent price action more clearly than any single-day move, especially after a volatile stretch in the broader managed-care group. MarketBeat also shows the consensus price target at $178.53 as of 05/31/2026, which provides a dated reference point for comparing current trading with published sell-side expectations.

Conclusion

Sunday's technical snapshot suggests the shares remain range-bound relative to the latest consensus price target, with the current quote below the 52-week midpoint and far under the high end of the cited range. For U.S. investors, the NYSE listing and the dated analyst consensus remain the key reference points until a new company update or broker revision changes the picture.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.